US Stock MarketDetailed Quotes

Armata Pharmaceuticals (ARMP)

Watchlist
  • 11.120
  • -0.410-3.56%
Close Apr 10 16:00 ET
  • 11.120
  • 0.0000.00%
Post 16:04 ET
407.36MMarket Cap-2.32P/E (TTM)

Armata Pharmaceuticals (ARMP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.39%-25.76M
15.81%-6.67M
51.51%-4.3M
29.14%-7.21M
28.38%-7.58M
20.82%-37.55M
2.21%-7.93M
8.51%-8.86M
15.61%-10.18M
39.76%-10.58M
Net income from continuing operations
-818.79%-173.8M
-4,880.69%-124.3M
-386.68%-26.68M
-281.34%-16.3M
73.90%-6.53M
72.60%-18.92M
113.10%2.6M
82.41%-5.48M
353.34%8.99M
-72.68%-25.02M
Operating gains losses
----
----
----
----
----
-154.92%-2.17M
----
----
----
----
Depreciation and amortization
15.55%1.53M
10.00%418K
18.21%370K
16.19%366K
18.93%377K
36.32%1.33M
29.69%380K
41.63%313K
38.16%315K
37.83%317K
Other non cash items
852.61%139.9M
1,181.24%111.2M
670.58%19.57M
150.31%10.14M
-106.61%-1.01M
-173.14%-18.59M
-196.86%-10.28M
-119.41%-3.43M
-233.86%-20.15M
383.18%15.28M
Change In working capital
32.73%-1.41M
-102.78%-33K
294.01%1.81M
-201.97%-2M
29.26%-1.2M
78.24%-2.1M
113.46%1.19M
-1,116.30%-935K
77.71%-661K
76.91%-1.69M
-Change in prepaid assets
-99.24%39K
-93.56%194K
318.45%1.02M
-324.08%-1.71M
-70.01%539K
5.80%5.11M
-38.53%3.01M
-121.83%-466K
196.83%764K
226.73%1.8M
-Change in payables and accrued expense
81.14%-423K
103.71%38K
124.52%1.05M
92.63%-28K
-13.61%-1.49M
-119.69%-2.24M
-67.05%-1.02M
127.67%469K
-123.27%-380K
41.79%-1.31M
-Change in other current liabilities
79.28%-1.03M
66.79%-265K
72.60%-257K
75.50%-256K
88.54%-250K
63.11%-4.96M
78.59%-798K
58.29%-938K
72.57%-1.05M
40.47%-2.18M
Cash from discontinued investing activities
Operating cash flow
31.39%-25.76M
15.81%-6.67M
51.51%-4.3M
29.14%-7.21M
28.38%-7.58M
20.82%-37.55M
2.21%-7.93M
8.51%-8.86M
15.61%-10.18M
39.76%-10.58M
Investing cash flow
Cash flow from continuing investing activities
71.15%-542K
-167.53%-52K
28.82%-242K
89.09%-149K
60.40%-99K
76.90%-1.88M
103.22%77K
90.32%-340K
-515.32%-1.37M
87.56%-250K
Net PPE purchase and sale
71.15%-542K
-167.53%-52K
28.82%-242K
89.09%-149K
60.40%-99K
76.90%-1.88M
103.22%77K
90.32%-340K
-515.32%-1.37M
87.56%-250K
Cash from discontinued investing activities
Investing cash flow
71.15%-542K
-167.53%-52K
28.82%-242K
89.09%-149K
60.40%-99K
76.90%-1.88M
103.22%77K
90.32%-340K
-515.32%-1.37M
87.56%-250K
Financing cash flow
Cash flow from continuing financing activities
-26.73%25.61M
658K
24,637.70%14.97M
0
-71.41%9.99M
-35.25%34.96M
0
-100.25%-61K
123.91%88K
18.03%34.93M
Net issuance payments of debt
-28.34%25M
--0
--15M
--0
-71.34%10M
-35.42%34.89M
--0
--0
--0
17.89%34.89M
Proceeds from stock option exercised by employees
406.15%658K
--658K
--0
--0
--0
2,500.00%130K
--0
--0
--88K
--42K
Net other financing activities
24.59%-46K
--0
---32K
--0
---14K
-41.86%-61K
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
-26.73%25.61M
--658K
24,637.70%14.97M
--0
-71.41%9.99M
-35.25%34.96M
--0
-100.25%-61K
123.91%88K
18.03%34.93M
Net cash flow
Beginning cash position
-23.24%14.77M
-10.94%20.15M
-69.52%9.72M
-60.60%17.08M
-23.24%14.77M
-7.54%19.24M
-24.04%22.62M
75.42%31.89M
40.60%43.34M
-7.54%19.24M
Current changes in cash
84.50%-693K
22.70%-6.07M
212.56%10.43M
35.75%-7.36M
-90.43%2.31M
-185.02%-4.47M
25.51%-7.85M
-179.82%-9.26M
9.45%-11.46M
140.63%24.1M
End cash Position
-4.69%14.08M
-4.69%14.08M
-10.94%20.15M
-69.52%9.72M
-60.60%17.08M
-23.24%14.77M
-23.24%14.77M
-24.04%22.62M
75.42%31.89M
40.60%43.34M
Free cash flow
33.29%-26.31M
14.32%-6.73M
50.67%-4.54M
36.24%-7.36M
29.12%-7.68M
29.04%-39.43M
25.28%-7.85M
30.28%-9.2M
6.02%-11.54M
44.67%-10.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.39%-25.76M15.81%-6.67M51.51%-4.3M29.14%-7.21M28.38%-7.58M20.82%-37.55M2.21%-7.93M8.51%-8.86M15.61%-10.18M39.76%-10.58M
Net income from continuing operations -818.79%-173.8M-4,880.69%-124.3M-386.68%-26.68M-281.34%-16.3M73.90%-6.53M72.60%-18.92M113.10%2.6M82.41%-5.48M353.34%8.99M-72.68%-25.02M
Operating gains losses ---------------------154.92%-2.17M----------------
Depreciation and amortization 15.55%1.53M10.00%418K18.21%370K16.19%366K18.93%377K36.32%1.33M29.69%380K41.63%313K38.16%315K37.83%317K
Other non cash items 852.61%139.9M1,181.24%111.2M670.58%19.57M150.31%10.14M-106.61%-1.01M-173.14%-18.59M-196.86%-10.28M-119.41%-3.43M-233.86%-20.15M383.18%15.28M
Change In working capital 32.73%-1.41M-102.78%-33K294.01%1.81M-201.97%-2M29.26%-1.2M78.24%-2.1M113.46%1.19M-1,116.30%-935K77.71%-661K76.91%-1.69M
-Change in prepaid assets -99.24%39K-93.56%194K318.45%1.02M-324.08%-1.71M-70.01%539K5.80%5.11M-38.53%3.01M-121.83%-466K196.83%764K226.73%1.8M
-Change in payables and accrued expense 81.14%-423K103.71%38K124.52%1.05M92.63%-28K-13.61%-1.49M-119.69%-2.24M-67.05%-1.02M127.67%469K-123.27%-380K41.79%-1.31M
-Change in other current liabilities 79.28%-1.03M66.79%-265K72.60%-257K75.50%-256K88.54%-250K63.11%-4.96M78.59%-798K58.29%-938K72.57%-1.05M40.47%-2.18M
Cash from discontinued investing activities
Operating cash flow 31.39%-25.76M15.81%-6.67M51.51%-4.3M29.14%-7.21M28.38%-7.58M20.82%-37.55M2.21%-7.93M8.51%-8.86M15.61%-10.18M39.76%-10.58M
Investing cash flow
Cash flow from continuing investing activities 71.15%-542K-167.53%-52K28.82%-242K89.09%-149K60.40%-99K76.90%-1.88M103.22%77K90.32%-340K-515.32%-1.37M87.56%-250K
Net PPE purchase and sale 71.15%-542K-167.53%-52K28.82%-242K89.09%-149K60.40%-99K76.90%-1.88M103.22%77K90.32%-340K-515.32%-1.37M87.56%-250K
Cash from discontinued investing activities
Investing cash flow 71.15%-542K-167.53%-52K28.82%-242K89.09%-149K60.40%-99K76.90%-1.88M103.22%77K90.32%-340K-515.32%-1.37M87.56%-250K
Financing cash flow
Cash flow from continuing financing activities -26.73%25.61M658K24,637.70%14.97M0-71.41%9.99M-35.25%34.96M0-100.25%-61K123.91%88K18.03%34.93M
Net issuance payments of debt -28.34%25M--0--15M--0-71.34%10M-35.42%34.89M--0--0--017.89%34.89M
Proceeds from stock option exercised by employees 406.15%658K--658K--0--0--02,500.00%130K--0--0--88K--42K
Net other financing activities 24.59%-46K--0---32K--0---14K-41.86%-61K--0------------
Cash from discontinued financing activities
Financing cash flow -26.73%25.61M--658K24,637.70%14.97M--0-71.41%9.99M-35.25%34.96M--0-100.25%-61K123.91%88K18.03%34.93M
Net cash flow
Beginning cash position -23.24%14.77M-10.94%20.15M-69.52%9.72M-60.60%17.08M-23.24%14.77M-7.54%19.24M-24.04%22.62M75.42%31.89M40.60%43.34M-7.54%19.24M
Current changes in cash 84.50%-693K22.70%-6.07M212.56%10.43M35.75%-7.36M-90.43%2.31M-185.02%-4.47M25.51%-7.85M-179.82%-9.26M9.45%-11.46M140.63%24.1M
End cash Position -4.69%14.08M-4.69%14.08M-10.94%20.15M-69.52%9.72M-60.60%17.08M-23.24%14.77M-23.24%14.77M-24.04%22.62M75.42%31.89M40.60%43.34M
Free cash flow 33.29%-26.31M14.32%-6.73M50.67%-4.54M36.24%-7.36M29.12%-7.68M29.04%-39.43M25.28%-7.85M30.28%-9.2M6.02%-11.54M44.67%-10.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More